[Reducing COPD exacerbations : a challenge in 2017]

Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of death in our country. Exacerbations play a major role in the course of the disease. Their consequences are multiple : accelerated decline in lung function, deterioration in patients’ quality of life and well-being, decreased physical activity, increased morbidity and mortality related to COPD, significant economic implications on health budgets and workplace absenteeism. Reducing the number of exacerbations in patients with COPD therefore represents a major challenge in the treatment of this disease. In this article, we underline the importance of these exacerbations and review the therapeutic means available in 2017 to prevent them.